Indian Billionaire Dilip Shanghvi’s Sun Pharma To Buy U.S. Cancer Drug Maker For $355 Million
Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...
Sun Pharma Shares Soar After ₹3,000 Crore Acquisition Of US-Based Biotech Company
Sun Pharma shares rose like the sun in the intraday trade on Tuesday, as the company shares surged by over 2 per cent in the ...
moneycontrol.com7d
Sun Pharma shares rise over 3% with positive brokerage outlook as firm to acquire US biotech company
Sun Pharmaceutical Industries Limited shares gained over 3 percent on Tuesday, March 11, after ICICI Securities' upgrade on rating the stock to 'Buy'. This adds to the continued positive investor ...
Reuters8d
India's Sun Pharma to acquire Checkpoint Therapeutics for $355 million
March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...
India's Sun Pharma buys onco-derma firm Checkpoint Therapeutics for $355M
India's pharma giant Sun Pharma is to acquire Checkpoint Therapeutics (NASDAQ:CKPT)—an immunotherapy and targeted ...